Učitavanje...
Getting personal with myelodysplastic syndromes: is now the right time?
INTRODUCTION: Commonly used scoring systems rely on blood counts, histological and cytological examination of bone marrow and peripheral blood, and cytogenetic assessments to estimate prognosis of patients with myelodysplastic syndromes (MDS) and guide therapy decisions. Next generation sequencing (...
Spremljeno u:
| Izdano u: | Expert Rev Hematol |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6540985/ https://ncbi.nlm.nih.gov/pubmed/30977414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474086.2019.1592673 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|